Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005794-02-000211
Filing Date
2002-12-19
Accepted
2002-12-19 11:16:21
Documents
1
Period of Report
2002-12-17

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF BENEFICIAL OWNERSHIP f4jmg121902.txt 4 9178
  Complete submission text file 0001005794-02-000211.txt   11063
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Subject) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-26372 | Film No.: 02862587
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 340 EDGEMONT AVE SUITE 500 BRISTOL TN 37620 4239897211
GREGORY JOHN M (Reporting) CIK: 0001200376 (see all company filings)